Advertisement

Topics

New strategy allows researchers to identify potential treatments for altered levels of MeCP2

03:18 EDT 24 Aug 2017 | News-Medical.net

Having twice the normal amount of the protein MeCP2, a condition called MECP2 duplication syndrome, causes severe progressive neuropsychiatric disorders that include intellectual disability, autism spectrum disorders, motor dysfunction and other medical complications.

Original Article: New strategy allows researchers to identify potential treatments for altered levels of MeCP2

NEXT ARTICLE

More From BioPortfolio on "New strategy allows researchers to identify potential treatments for altered levels of MeCP2"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...